stars 1 stars 2 stars 3

Epify develops epigenetic biomarkers which control gene activity and are implicated in a wide range of cancers, driving and influencing the development of the disease. Using these biomarkers, Epify aims to drive earlier detection and more accurate diagnosis, facilitating personalized oncology and better outcomes for cancer patients.

Epify BV Questions

Epify BV is based in Maastricht, Limburg.

The NAICS codes for Epify BV are [54, 5417, 541713, 54171, 541].

The SIC codes for Epify BV are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users